Stockreport

Tiziana Life Sciences to Dose First Patient in Phase 2 Alzheimer's Trial [Yahoo! Finance]

Tiziana Life Sciences Ltd - Common Shares  (TLSA) 
PDF BOSTON, Dec. 12, 2025 (GLOBE NEWSWIRE) -- Tiziana Life Sciences, Ltd. (Nasdaq: TLSA ) (“Tiziana” or the “Company”), a biotechnology company developing breakthrough immu [Read more]